Verition Fund Management LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 35 filers reported holding HAEMONETICS CORP MASS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$16,396,020
+25.3%
18,792
+22.9%
0.19%
+9.1%
Q2 2023$13,088,384
+35.4%
15,292
+35.0%
0.18%
+30.6%
Q1 2023$9,664,840
+30.1%
11,324
-99.9%
0.13%
+15.5%
Q4 2022$7,427,666
+8.2%
8,935,000
-47.9%
0.12%
+48.7%
Q3 2022$6,863,857
+93.7%
17,142,000
+380833.3%
0.08%
+11.4%
Q2 2022$3,544,000
-53.3%
4,500
-100.0%
0.07%
-23.1%
Q1 2022$7,585,0009,000,0000.09%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2022
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders